<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Cir Cardiovasc</journal-id><journal-title-group><journal-title>Revista Brasileira de Cirurgia Cardiovascular : &#x000f3;rg&#x000e3;o oficial da Sociedade Brasileira de Cirurgia Cardiovascular</journal-title></journal-title-group><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25714214</article-id><article-id pub-id-type="pmc">4408823</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20140047</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Pleural subxyphoid drain confers better pulmonary function and clinical
outcomes in chronic obstructive pulmonary disease after off-pump coronary artery
bypass grafting: a randomized controlled trial</article-title><trans-title-group xml:lang="pt"><trans-title>Dreno pleural subxifoide confere melhor fun&#x000e7;&#x000e3;o pulmonar e resultados
cl&#x000ed;nicos na doen&#x000e7;a pulmonar obstrutiva cr&#x000f4;nica ap&#x000f3;s cirurgia de revasculariza&#x000e7;&#x000e3;o
mioc&#x000e1;rdica sem circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea: ensaio cl&#x000ed;nico controlado e
randomizado</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guizilini</surname><given-names>Solange</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>Viceconte</surname><given-names>Marcela</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Esperan&#x000e7;a</surname><given-names>Gabriel Tavares da M.</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Bolzan</surname><given-names>Douglas W.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Vidotto</surname><given-names>Milena</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Rita Simone L</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>C&#x000e2;ncio</surname><given-names>Andr&#x000e9;ia Azevedo</given-names></name><degrees>MsC</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Walter J</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib></contrib-group><aff id="aff01"><label>1</label>Cardiology and Cardiovascular Surgery Discipline, S&#x000e3;o Paulo
Hospital, Escola Paulista de Medicina, Department of Human Motion Sciences, Physical
Therapy School &#x02013; Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff02"><label>2</label>Cardiology and Cardiovascular Surgery Discipline, S&#x000e3;o Paulo
Hospital, Escola Paulista de Medicina, Universidade Federal de S&#x000e3;o Paulo (Unifesp), S&#x000e3;o
Paulo, SP, Brazil.</aff><author-notes><corresp id="c01">Correspondence address: Solange Guizilini, Universidade Federal de S&#x000e3;o
Paulo (Unifesp), Rua Botucatu, 740 - Vila Clementino - S&#x000e3;o Paulo, SP, Brazil, Zip
code: 04023-062. E-mail: <email>sguizilini@unifesp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2014</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2014</year></pub-date><volume>29</volume><issue>4</issue><fpage>588</fpage><lpage>594</lpage><history><date date-type="received"><day>24</day><month>10</month><year>2013</year></date><date date-type="accepted"><day>13</day><month>1</month><year>2014</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate the lung function and clinical outcome in severe chronic obstructive
pulmonary disease in patients undergoing off-pump coronary artery bypass grafting
with left internal thoracic artery graft, comparing the pleural drain insertion in
the intercostal versus subxyphoid region.</p></sec><sec><title>Methods</title><p>A randomized controlled trial. Chronic obstructive pulmonary disease patients were
randomized into two groups according pleural drain site: II group (n=27) - pleural
drain in intercostal space; SI group (n=29) - pleural drain in the subxyphoid
region. Spirometry values (Forced Vital Capacity - and Forced expiratory volume in
1 second) were obtained on preoperative and 1, 3 and 5 postoperative days. Chest
x-ray from preoperative until postoperative day 5 (POD5) was performed for
monitoring respiratory events, such as atelectasis and pleural effusion. Pulmonary
shunt fraction and pain score was evaluate preoperatively and on postoperative day
1.</p></sec><sec><title>Results</title><p>In both groups there was a significant decrease of the spirometry values (Forced
Vital Capacity and Forced expiratory volume in 1 second) until POD5 (P&#x0003c;0.05).
However, when compared, SI group presented less decrease in these parameters
(P&#x0003c;0.05). Pulmonary shunt fraction was significantly lower in SI group
(P&#x0003c;0.05). Respiratory events, pain score, orotracheal intubation time and
postoperative length of hospital stay were lower in the SI group (P&#x0003c;0.05).</p></sec><sec><title>Conclusion</title><p>Subxyphoid pleural drainage in severe Chronic obstructive pulmonary disease
patients determined better preservation and recovery of pulmonary capacity and
volumes with lower pulmonary shunt fraction and better clinical outcomes on early
postoperative off-pump coronary artery bypass grafting.</p></sec></abstract><trans-abstract xml:lang="pt"><sec><title>Objetivo</title><p>Avaliar a fun&#x000e7;&#x000e3;o pulmonar e os resultados cl&#x000ed;nicos em pacientes com doen&#x000e7;a
pulmonar obstrutiva cr&#x000f4;nica grave submetidos &#x000e0; cirurgia de revasculariza&#x000e7;&#x000e3;o do
mioc&#x000e1;rdio sem circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea, com enxerto da art&#x000e9;ria tor&#x000e1;cica interna
esquerda, comparando a inser&#x000e7;&#x000e3;o do dreno pleural intercostal versus
subxifoide.</p></sec><sec><title>M&#x000e9;todos</title><p>Estudo cl&#x000ed;nico, controlado e randomizado. Pacientes com doen&#x000e7;a pulmonar obstrutiva
cr&#x000f4;nica foram randomizados em dois grupos de acordo com a posi&#x000e7;&#x000e3;o do dreno
pleural: grupo II (n=27) - dreno pleural intercostal; grupo IS (n=29) - dreno
pleural na regi&#x000e3;o subxif&#x000f3;ide. Os valores espirom&#x000e9;tricos (Capacidade Vital For&#x000e7;ada
e Volume expirat&#x000f3;rio for&#x000e7;ado no 1 segundo) foram obtidos no pr&#x000e9;-operat&#x000f3;rio, e no
1&#x000ba;, 3&#x000ba; e 5&#x000ba; dias de p&#x000f3;s-operat&#x000f3;rio. Foi realizada radiografia de t&#x000f3;rax no
pr&#x000e9;operat&#x000f3;rio at&#x000e9; o 5&#x000ba; dia p&#x000f3;s-operat&#x000f3;rio (5PO) para monitora&#x000e7;&#x000e3;o de eventos
respirat&#x000f3;rios, como atelectasia e derrame pleural. A fra&#x000e7;&#x000e3;o de shunt pulmonar e a
escala de dor foram avaliadas no 1&#x000ba; dia p&#x000f3;s-operat&#x000f3;rio.</p></sec><sec><title>Resultados</title><p>Em ambos os grupos houve queda significativa dos valores espirom&#x000e9;tricos
(Capacidade Vital For&#x000e7;ada e Volume expirat&#x000f3;rio for&#x000e7;ado no 1 segundo) at&#x000e9; o 5PO
(P&#x0003c;0.05), por&#x000e9;m, quando comparados, o grupo IS apresentou menor queda destes
par&#x000e2;metros (P&#x0003c;0.05). A fra&#x000e7;&#x000e3;o de shunt pulmonar foi significativamente menor no
grupo IS (P&#x0003c;0.05). Os eventos respirat&#x000f3;rios, escala da dor, tempo de intuba&#x000e7;&#x000e3;o
orotraqueal e dias interna&#x000e7;&#x000e3;o hospitalar no p&#x000f3;s-operat&#x000f3;rio foram menores no grupo
IS (P&#x0003c;0.05).</p></sec><sec><title>Conclus&#x000e3;o</title><p>Drenagem pleural subxifoide em pacientes com doen&#x000e7;a pulmonar obstrutiva cr&#x000f4;nica
grave determinou melhor preserva&#x000e7;&#x000e3;o e recupera&#x000e7;&#x000e3;o dos volumes e capacidades
pulmonares, com menor fra&#x000e7;&#x000e3;o de shunt pulmonar e melhores resultados cl&#x000ed;nicos no
p&#x000f3;s-operat&#x000f3;rio precoce de cirurgia de revasculariza&#x000e7;&#x000e3;o do mioc&#x000e1;rdio sem circula&#x000e7;&#x000e3;o
extracorp&#x000f3;rea.</p></sec></trans-abstract><kwd-group><kwd>Pulmonary Disease, Chronic Obstructive</kwd><kwd>Respiratory Function Tests</kwd><kwd>Coronary Artery Bypass, Off-Pump</kwd></kwd-group></article-meta></front><body><table-wrap id="t01" orientation="portrait" position="float"><table frame="box" rules="groups"><thead><tr align="left"><th colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">CABG</td><td rowspan="1" colspan="1">Coronary artery bypass graft</td></tr><tr><td rowspan="1" colspan="1">COPD</td><td rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td></tr><tr><td rowspan="1" colspan="1">FEV1</td><td rowspan="1" colspan="1">Forced expiratory volume in 1 second</td></tr><tr><td rowspan="1" colspan="1">FVC</td><td rowspan="1" colspan="1">Forced Vital Capacity</td></tr><tr><td rowspan="1" colspan="1">ITA</td><td rowspan="1" colspan="1">Internal thoracic artery</td></tr><tr><td rowspan="1" colspan="1">OPCAB</td><td rowspan="1" colspan="1">Off-pump coronary artery bypass grafting</td></tr><tr><td rowspan="1" colspan="1">POD</td><td rowspan="1" colspan="1">Postoperative day</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Chronic obstructive pulmonary disease (COPD) has been associated with increased
morbidity and mortality in patients undergoing coronary artery bypass graft
(CABG)<sup>[<xref rid="r01" ref-type="bibr">1</xref>]</sup>. Many studies showed
that as higher severity degree of COPD is associated to longer mechanical ventilation
time and length of stay in the hospital and, consequently, increased hospital
costs<sup>[<xref rid="r02" ref-type="bibr">2</xref>]</sup>. Furthermore, severe
COPD patients undergoing CABG have a worse prognosis and increased mortality rate at
long-term, when compared to patients without COPD<sup>[<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>]</sup>.</p><p>Several factors may influence pulmonary function and clinical results in patients
undergoing CABG, such as: general anesthesia, sternotomy, cardiopulmonary bypass,
internal thoracic artery (ITA) graft with pleurotomy and pleural drain<sup>[<xref rid="r05" ref-type="bibr">5</xref>]</sup>. Pleural drain insertion through
intercostal space promotes higher thoracic trauma, increased pain and discomfort for the
patient, leading to increased vulnerability to lung complications. In patients without
COPD undergoing off-pump CABG (OPCAB), the shift of pleural drain insertion to
subxyphoid region reduces postoperative pulmonary dysfunction<sup>[<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref>]</sup>. Our hypothesis
is that reducing thoracic trauma in COPD patients underwent OPCAB could determine lower
impairment to the lung function and better clinical results.</p><p>Therefore, the aim of this study was to evaluate the pulmonary function and clinical
outcomes in severe COPD patients, comparing pleural drain insertion site in intercostal
space versus subxyphoid region after OPCAB using left ITA (LITA).</p></sec><sec sec-type="methods"><title>METHODS</title><p>This prospective randomized study was performed between December 2007 and March 2012 at
the Cardiovascular Surgery Discipline, Sao Paulo and Pirajussara Hospitals of the
Federal University of Sao Paulo, Sao Paulo, Brazil. The Institutional Human Ethics
Committee approved the protocol and written informed consent was obtained from all
patients.</p><sec><title>Patients study group</title><p>Patients of both sexes, age between 35 and 75 years old, coronary disease confirmed
by coronary angiography, undergoing elective OPCAB using LITA, with an ejection
fraction &#x0003e; 50%, and severe COPD were included in this study. We excluded patients
unable to perform spirometry, with hemodynamic instability, intraoperative death,
renal failure (creatinine &#x0003e;1.3 mg/dL), intact pleura, intraoperative complications
requiring on-pump CABG conversion and patients who required additional analgesia.</p><p>The subjects were randomized into two groups by computerized system according to
pleural drain position and the secrecy was maintained by sealed, numbered and opaque
envelopes: II group (n=27), pleural drain was inserted in the sixth intercostals
space; and SI group (n=29), pleural drain in the subxyphoid position.</p></sec><sec><title>Lung function assessment</title><p>Spirometry records were obtained to evaluate the forced vital capacity (FVC) and the
forced expiratory volume in 1 second (FEV<sub>1</sub>) on preoperative and
postoperative days 1, 3, and 5 (POD1, POD3, POD5) by the same respiratory
physiotherapist, using a portable espirometer (Spirobank G, MIR, Rome, Italy)
according to the standards of the American Thoracic Society<sup>[<xref rid="r08" ref-type="bibr">8</xref>]</sup>. Chronic obstructive pulmonary
disease was defined according to the criteria of the Global Initiative for Chronic
Obstructive Lung Disease - GOLD, with presence of dyspnea (progressive and/or
persistent), chronic cough or sputum production, and/or a history of exposure to risk
factors for the disease (tobacco smoking, occupational dusts and chemical), and by
spirometry with FEV<sub>1</sub>/FVC &#x0003c; 0.70. Furthermore, the severity of COPD was
defined as described on <xref ref-type="table" rid="t02">Table 1</xref><sup>[<xref rid="r09" ref-type="bibr">9</xref>]</sup>.</p><p>Pulmonary shunt fraction was evaluated preoperatively and on POD1 using the software
Oxygen Status Algorithm, (version 2.0; Mads &#x00026; Ole Siggaard; Radiometer). This
software needs the arterial blood gas and the fraction of inspired oxygen to
calculate the percentage of blood that is not supplied by oxygen.</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 1</label><caption><p>Chronic obstructive pulmonary disease stage classification according to GOLD
Guidelines.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1">Stage I:</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">mild COPD</td><td rowspan="1" colspan="1">FEV<sub>1</sub>/CVF &#x0003c; 70% andFEV<sub>1</sub> &#x02265; 80%</td></tr><tr><td rowspan="1" colspan="1">Stage II:</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">moderate COPD</td><td rowspan="1" colspan="1">FEV<sub>1</sub>/CVF &#x0003c; 70% and 50% &#x02264; FEV<sub>1</sub>&#x0003c; 80%</td></tr><tr><td rowspan="1" colspan="1">Stage III:</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">severe COPD</td><td rowspan="1" colspan="1">FEV<sub>1</sub>/CVF &#x0003c; 70% and 30% &#x02264; FEV<sub>1</sub>&#x0003c; 50%</td></tr><tr><td rowspan="1" colspan="1">Stage IV:</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">very severe COPD</td><td rowspan="1" colspan="1">FEV<sub>1</sub>/CVF &#x0003c; 70% and FEV<sub>1</sub>&#x0003c; 30%</td></tr></tbody></table><table-wrap-foot><fn><p>COPD = Chronic obstructive pulmonary disease; FEV<sub>l</sub>=Forced
expiratory volume in 1 second; FVC=forced vital capacity; GOLD =Global
Initiative for Chronic Obstructive Lung Disease</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Anesthesia and ventilation management</title><p>All patients received a standard anesthetic technique, induction with etomidate and
midazolam, maintenance with sufentanil and isofluorane (0.5% to 1%) and were
mechanically ventilated to maintain normocapnia, with a 50% inspired oxygen fraction
without positive end-expiratory pressure. Intraoperative fluids were given according
to the anesthetist discretion.</p></sec><sec><title>Operative technique</title><p>The OPCAB surgery was performed through a median sternotomy, using LITA complemented
with additional saphenous vein grafts. The LITA was harvested in a skeletonized
fashion. A heated water mattress was used to keep all patients normothermic
throughout the operation. OPCAB has followed the pattern at our service. Briefly,
with systemic heparinization to achieve an activated clotting time exceeding 250
seconds, occlusion of the coronary artery was accomplished by using a proximal soft
silicone snare. The distal anastomosis was accomplished with a 7-0 running
polypropylene suture. The vein top ends were then attached to the ascending aorta
using side-bite clamping. An Octopus 3 (Medtronic, Inc, Minneapolis, MN) suction
stabilizer was used in all cases. Before chest closure, and in the presence of left
pleura opening, the site of pleural drain insertion was randomized. A soft tubular
straight PVC drain (&#x000bc; inch) was inserted and exteriorized at the intersection of the
sixth left intercostal space (Group II) or a curved one at the subxyphoid region and
positioned in the left costophrenic sinus (Group SI). In all patients, a straight
mediastinal drain was also placed via a subxyphoid approach.</p></sec><sec><title>Postoperative Management</title><p>All patients were transferred to the intensive care unit (ICU) with orotracheal
intubation, inspired oxygen fraction to keep arterial oxygen saturation above 90%,
predicted tidal volume of 8 ml/kg, PEEP of 5 cmH<sub>2</sub>O and extubated according
to ICU protocol. The drains (mediastinal and/or pleural) were routinely removed on
POD2.</p><p>During postoperative days, the patients were evaluated by the same physiotherapist
and all patients were undergone to the same physical therapy program until hospital
discharge (breathing exercises and early deambulation).</p></sec><sec><title>Clinical Outcomes</title><p>All patients underwent to the same analgesic protocol administered during the
postoperative period (100mg of tramadol chlorhydrate 4 times a day). Pain was
evaluated and quantified by Visual Analogical Scale (VAS)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup> (0 = no pain to 10 = unbearable pain) on POD1 and
before spirometry. Total orotracheal intubation time and length of hospital stay
after surgery were also recorded.</p><p>The patients were undergoing chest radiography on preoperative, POD1, POD3 and POD5
for monitoring respiratory events, like pleural effusion and atelectasis. The
radiological evaluation was performed by the same radiologist, blinded to the study.
The pleural effusion was deemed significant when exceeding the costophrenic angle.
Atelectasis was acknowledged when a clear atelectasis radiologic shadow exceeded 15
mm in width, with linear atelectasis being disregarded in this study.</p></sec><sec><title>Statistical analysis</title><p>Data were expressed as mean &#x000b1; standard deviation. The FVC, FEV<sub>1</sub> were
analyzed, and values are expressed as a percentage of the preoperative value
considered as 100% the preoperative baseline value. Intragroup variables comparing
pre versus postoperative values were evaluated by paired Student t tests and analysis
of variance for repeated measures with the Newman-Keuls posttest. Differences between
groups were analyzed by unpaired Student t test or the Mann-Whitney test, when
necessary. The categoric data were analyzed by the Pearson chi-square test.
Statistical analysis was performed with GraphPad Prism 3.0 software (Graph-Pad
Software Inc, San Diego, CA). A value of <italic>P</italic> &#x0003c;0.05 was considered
statistically significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Initially, 165 subjects were selected for this study, however, 95 were excluded in the
pre- and intraoperative, 14 were lost to follow-up and 56 were actually analyzed
according to <xref ref-type="fig" rid="f01">Figure 1</xref>. Groups were homogeneous
preoperatively in terms of age, gender, body mass index (BMI), preoperative pulmonary
function, operative time, number of grafts per patients with no significant
statistically differences, as shown in <xref ref-type="table" rid="t03">Table
2</xref>.</p><fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow diagram of the progress through the phases of a randomized trial.</p></caption><graphic xlink:href="rbccv-29-04-0588-g01"/></fig><table-wrap id="t03" orientation="portrait" position="float"><label>Table 2</label><caption><p>Baseline patient characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" valign="bottom" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Group II</th><th align="center" rowspan="1" colspan="1">Group SI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr><tr><th rowspan="1" colspan="1">(N=27)</th><th rowspan="1" colspan="1">(N=29)</th><th rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">59.22 &#x000b1; 11.73</td><td align="center" rowspan="1" colspan="1">56.66 &#x000b1; 10.33</td><td align="center" rowspan="1" colspan="1">0.32</td></tr><tr><td rowspan="1" colspan="1">Gender (n)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Male/ Female</td><td align="center" rowspan="1" colspan="1">18/9</td><td align="center" rowspan="1" colspan="1">20/9</td><td align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">24.52 &#x000b1; 3.56</td><td align="center" rowspan="1" colspan="1">26.12&#x000b1; 4.61</td><td align="center" rowspan="1" colspan="1">0.24</td></tr><tr><td colspan="4" rowspan="1">Pulmonary function</td></tr><tr><td rowspan="1" colspan="1">FVC (L)</td><td align="center" rowspan="1" colspan="1">3.27 &#x000b1; 0.26</td><td align="center" rowspan="1" colspan="1">3.51&#x000b1; 0.45</td><td align="center" rowspan="1" colspan="1">0.39</td></tr><tr><td rowspan="1" colspan="1">% predicted</td><td align="center" rowspan="1" colspan="1">98.2 &#x000b1; 21.70</td><td align="center" rowspan="1" colspan="1">101.25 &#x000b1; 25.24</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">FEV1 (L)</td><td align="center" rowspan="1" colspan="1">1.40 &#x000b1; 0.35</td><td align="center" rowspan="1" colspan="1">1.37 &#x000b1; 0.22</td><td align="center" rowspan="1" colspan="1">0.32</td></tr><tr><td rowspan="1" colspan="1">% predicted</td><td align="center" rowspan="1" colspan="1">40.32 &#x000b1; 7.22</td><td align="center" rowspan="1" colspan="1">38.21 &#x000b1; 9.07</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Pulmonary shunt</td><td align="center" rowspan="1" colspan="1">0.03 &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">0.04 &#x000b1; 0.02</td><td align="center" rowspan="1" colspan="1">0.10</td></tr><tr><td rowspan="1" colspan="1">fraction (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Surgery time (min)</td><td align="center" rowspan="1" colspan="1">314.8 &#x000b1; 29.78</td><td align="center" rowspan="1" colspan="1">309.4 &#x000b1; 21.98</td><td align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td rowspan="1" colspan="1">Grafts per patient (n)</td><td align="center" rowspan="1" colspan="1">2.71 &#x000b1; 0.42</td><td align="center" rowspan="1" colspan="1">2.62 &#x000b1; 0.77</td><td align="center" rowspan="1" colspan="1">0.39</td></tr></tbody></table><table-wrap-foot><fn><p>Data are shown as mean &#x000b1; standard deviation. BMI = body mass index;
FEV<sub>1</sub> = Forced expiratory volume in 1 second; FVC = forced vital
capacity; II = intercostal insertion; SI = subxyphoid insertion.</p></fn></table-wrap-foot></table-wrap><p>No signs of preoperative myocardial infarction were detected in either group, as
assessed by electrocardiographic changes or enzyme elevation.</p><p>In the postoperative period, the both groups presented significant reduction in
spirometric parameters (FVC and FEV<sub>1</sub>) until POD5 (<italic>P</italic>
&#x0003c;0.05). However, when compared the values, the SI group presented lower impairment
(<xref ref-type="fig" rid="f02">Figure 2</xref>).</p><fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Pulmonary function test values on the POD1, 3 and 5, in percentage considering
100% preoperative baseline value.</p><p>Data are shown as mean &#x000b1; standard deviation. BMI=body mass index; FEV1=Forced
expiratory volume in 1 second; FVC=forced vital capacity; II=intercostal
insertion; SI=subxyphoid insertion.</p></caption><graphic xlink:href="rbccv-29-04-0588-g01"/></fig><p>The pulmonary shunt fraction increasein both groups, but was significantly lesser in SI
group (0.24&#x000b1;0.03% versus 0.28&#x000b1;0.04%; <italic>P</italic> &#x0003c;0.001).</p><p>In relation to respiratory events, lower incidence of atelectasis and pleural effusion
was observed in SI group (atelectasis: 21&#x000b1;3.4% versus 25&#x000b1;0.1%; <italic>P</italic> =0.001
e pleural effusion: 22&#x000b1;2.4% versus 26&#x000b1;1.7%; <italic>P</italic> =0.003).</p><p>The chest pain sensation was lesser in group SI than II group (4.6&#x000b1;3.4 versus 7.9&#x000b1;2.1,
<italic>P</italic> =0.001). Moreover, the time of mechanical ventilation and the
length of hospital stay was lower in SI group when compared to II group (13.98&#x000b1;1.4 hours
versus 16.25&#x000b1;2.1 hours; <italic>P</italic> =0.001; 9.51&#x000b1;1.6 days versus 12.1&#x000b1;1.4 days;
<italic>P</italic> &#x0003c;0.001).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The results demonstrated that both groups presented impairment in pulmonary function in
the early postoperative. However, the patients of SI group presented better pulmonary
function and clinical outcomes when compared to II group. This data corroborate with
findings by other studies with patients without COPD<sup>[<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>The lung dysfunction in postoperative period after CABG is associated with
intraoperative procedures. The use of general anesthesia<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>, the sternotomy<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>, cardiopulmonary bypass<sup>[<xref rid="r05" ref-type="bibr">5</xref>]</sup>, ITA graft with consequent pleurotomy and necessity of pleural
drain insertion make the pulmonary dysfunction unavoidable<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>The use of ITA graft for coronary revascularization is associated with higher survival
and less incidence of cardiovascular events when compared to saphenous vein
graft<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. The technique of
skeletonized ITA dissection has been proved beneficial to reduce sternal complications
or infections, due to better preservation of arterial branches supplying sternal and
intercostal muscles<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Beyond
reduction of blood supply, the manipulation of ITA may lead the opening of parietal
pleura<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. Consequently to
pleurotomy, pleural drainage becomes mandatory. In the majority of the operations, the
chest tube is inserted and exteriorized in the intercostal space, coming into contact
with the periosteum and the parietal pleura, which are highly sensitive. Therefore, the
use of intercostal chest tube can promote ventilatory-dependent pain, limiting deep
inspiration, which leads to the adoption of an antalgic posture, immobilization and
reduced lung volumes and capacities<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.</p><p>Recent studies have evaluated the postoperative clinical follow-up of patients
undergoing CABG, with exteriorization of the drain in the subxyphoid region, and
concluded that this strategy minimizes the pulmonary dysfunction in postoperative
period, with better spirometric parameters, lower rate of atelectasis and pleural
effusion, and lower pain intensity<sup>[<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>. Furthermore, Guizilini et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> observed that the insertion of a chest tube in the subxyphoid
region resulted in similar findings to CABG with intact pleura.</p><p>COPD can also be considered a risk factor for development of pulmonary dysfunction in
postoperative period of CABG. Fuster et al.<sup>[<xref rid="r02" ref-type="bibr">2</xref>]</sup> and Lizak et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> compared postoperative outcomes of patients with and without COPD
and observed that patients with COPD had a higher incidence of pulmonary complications
and hospital stay, more pronounced in patients with severe COPD.</p><p>Taking into account evidence that shifting the site of drain insertion to the subxyphoid
region may be beneficial for the postoperative clinical outcomes, and the fact that
patients with severe COPD have a higher risk of pulmonary complications in this period,
this study aimed to answer the following question: Do patients with clinically severe
COPD would benefit by shifting the drain position in the postoperative period of OPCAB
using the LITA graft? For our knowledge, no randomized controlled trial has evaluated
the impact of drain shifting in severe COPD patients undergoing OPCAB, which makes our
proposal innovative and original.</p><p>Previous studies compared the effectiveness of shifting the drain insertion site to the
subxyphoid region and reported lesser lung function impairment<sup>[<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. These findings corroborate the results
found in this study, reiterating the hypothesis that subxyphoid drain minimizes the
dysfunction in postoperative period of OPCAB surgery, even in patients with severe
COPD.</p><p>Regarding the chest pain, patients with subxyphoid drain reported less intensity on VAS.
The same result was reported in other studies with patients without COPD, which showed
less pain when the chest tube was inserted in the subxyphoid region<sup>[<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r21" ref-type="bibr">21</xref>]</sup>. Similar outcomes were found in this
study.</p><p>Sensoz et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup> evaluated patients
with COPD undergoing on-pump CABG by means of computed tomography. Patients who belonged
to the group with pleural drain in subxyphoid region evolved with a lower incidence of
atelectasis in postoperative period, corroborating the results found in this study.</p><p>Hypoxemia is also an unavoidable consequence in CABG postoperative, regardless of
surgical technique<sup>[<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref>]</sup>. There are many causes of hypoxemia, abnormal diffusion,
hypoventilation and shunt. In this study, the pulmonary shunt fraction was assessed on
the first postoperative day, which was significantly lower in the subxyphoid group.</p><p>These findings could be explained due to better preservation and recovery of FVC and
consequently decrease of pulmonary fraction shunt, reflects the chest wall lesser degree
of trauma in patients with pleural subxyphoid drain.</p><p>Fuster et al.<sup>[<xref rid="r02" ref-type="bibr">2</xref>]</sup> associated severe
COPD with higher incidence of pneumonia, sepsis and respiratory distress syndrome,
longer ICU stay, and greater number of hospitalization days in the postoperative period
of coronary revascularization. Saleh et al.<sup>[<xref rid="r01" ref-type="bibr">1</xref>]</sup> found that COPD severity is a significant prognostic marker in
clinical outcomes after CABG. In this study, we found similar results; however the SI
group presented shorter mechanical ventilation time and length of hospital stay, which
may be reflected in reduced hospital costs, although this finding was not evaluated.</p><p>This study has some limitations. The assessment of patients after surgery was not blind
because of the possibility to visualize the drain position in the rib cage, with
exception of radiological analyses; however the spirometry was performed according to
ATS standardization to confirm the airflow limitation, by the same evaluator, reducing
the evaluation bias. Furthermore, the sample size was limited by the tight inclusion
criteria restricted to severe COPD.</p><p>Considering the results of this study and others, it is clear that CABG elicits
postoperatively pulmonary dysfunction and may exacerbate in the existence of
comorbidities such as COPD. Drain shifting to the subxyphoid region is recommended for
further decreasing trauma to the chest and can be an alternative to minimize the
postoperative pulmonary dysfunction in this group of patients.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Subxyphoid pleural drainage in severe COPD patients determined better preservation and
recovery of pulmonary capacity and volumes with lower pulmonary shunt fraction and
better clinical outcomes on early postoperative OPCAB.</p><table-wrap id="t04" orientation="portrait" position="float"><table frame="box" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1">Authors&#x02019; roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">SG</td><td rowspan="1" colspan="1">Data collection and manuscript preparation</td></tr><tr><td rowspan="1" colspan="1">MV</td><td rowspan="1" colspan="1">Data collection and manuscript preparation</td></tr><tr><td rowspan="1" colspan="1">GTME</td><td rowspan="1" colspan="1">Data collection</td></tr><tr><td rowspan="1" colspan="1">DWB</td><td rowspan="1" colspan="1">Data collection</td></tr><tr><td rowspan="1" colspan="1">MV</td><td rowspan="1" colspan="1">Statistical analysis and data collection</td></tr><tr><td rowspan="1" colspan="1">RSLM</td><td rowspan="1" colspan="1">Manuscript preparation</td></tr><tr><td rowspan="1" colspan="1">AAC</td><td rowspan="1" colspan="1">Data collection</td></tr><tr><td rowspan="1" colspan="1">WJG</td><td rowspan="1" colspan="1">Review of the manuscript</td></tr></tbody></table></table-wrap></sec></body><back><ref-list><title>REFERENCES</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>HZ</given-names></name><name><surname>Mohan</surname><given-names>K</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Al-Rawi</surname><given-names>O</given-names></name><name><surname>Elsayed</surname><given-names>H</given-names></name><name><surname>Walshaw</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Impact of chronic obstructive pulmonary disease severity on surgical
outcomes in patients undergoing non-emergent coronary artery bypass
grafting</article-title><source>Eur J Cardiothorac Surg</source><year>2012</year><volume>42</volume><issue>1</issue><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">22290913</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuster</surname><given-names>RG</given-names></name><name><surname>Argudo</surname><given-names>JAM</given-names></name><name><surname>Albarova</surname><given-names>OG</given-names></name><name><surname>Sos</surname><given-names>FH</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>SC</given-names></name><name><surname>Codo&#x000f1;er</surname><given-names>MB</given-names></name><etal>et al</etal></person-group><article-title>Prognostic value of chronic obstructive pulmonary disease in coronary
artery bypass grafting</article-title><source>Eur J Cardiothorac Surg</source><year>2006</year><volume>29</volume><issue>2</issue><fpage>202</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">16376093</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>K</given-names></name><name><surname>Morimoto</surname><given-names>T</given-names></name><name><surname>Furukawa</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Ehara</surname><given-names>N</given-names></name><name><surname>Taniguchi</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Chronic obstructive pulmonary disease-an independent risk factor for
long-term cardiac and cardiovascular mortality in patients with ischemic heart
disease</article-title><source>Int J Cardiol</source><year>2010</year><volume>143</volume><issue>2</issue><fpage>178</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">19368979</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leavitt</surname><given-names>BJ</given-names></name><name><surname>Ross</surname><given-names>CS</given-names></name><name><surname>Spence</surname><given-names>B</given-names></name><name><surname>Surgenor</surname><given-names>SD</given-names></name><name><surname>Olmstead</surname><given-names>EM</given-names></name><name><surname>Clough</surname><given-names>RA</given-names></name><collab>Northern New England Cardiovascular Disease Study Group</collab><etal>et al</etal></person-group><article-title>Long-term survival of patients with chronic obstructive pulmonary
disease undergoing coronary artery bypass surgery</article-title><source>Circulation</source><year>2006</year><volume>114</volume><issue>1</issue><supplement>Suppl</supplement><fpage>I430</fpage><lpage>I434</lpage><pub-id pub-id-type="pmid">16820614</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Alves</surname><given-names>FA</given-names></name><name><surname>Catani</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Evaluation of pulmonary function in patients following on- and
off-pump coronary artery bypass grafting</article-title><source>Rev Bras Cir Cardiovasc</source><year>2005</year><volume>20</volume><issue>3</issue><fpage>310</fpage><lpage>316</lpage></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Carvalho</surname><given-names>ACC</given-names></name><name><surname>Jaramillo</surname><given-names>JI</given-names></name><name><surname>Alves</surname><given-names>FA</given-names></name><etal>et al</etal></person-group><article-title>Effects of the pleural drain site on the pulmonary function after
coronary artery bypass grafting</article-title><source>Rev Bras Cir Cardiovasc</source><year>2004</year><volume>19</volume><issue>1</issue><fpage>47</fpage><lpage>54</lpage></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cancio</surname><given-names>AS</given-names></name><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Dauar</surname><given-names>RB</given-names></name><name><surname>Succi</surname><given-names>JE</given-names></name><name><surname>de Paola</surname><given-names>AA</given-names></name><etal>et al</etal></person-group><article-title>Subxyphoid pleural drain confers lesser impairment in respiratory
muscle strength, oxygenation and lower chest pain after off-pump coronary artery
bypass grafting: a randomized controlled trial</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>1</issue><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">22729307</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society</collab></person-group><article-title>Standardization of spirometry: 1994 Update</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume>152</volume><issue>3</issue><fpage>1107</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">7663792</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestbo</surname><given-names>J</given-names></name><name><surname>Hurd</surname><given-names>SS</given-names></name><name><surname>Agust&#x000ed;</surname><given-names>AG</given-names></name><name><surname>Jones</surname><given-names>PW</given-names></name><name><surname>Vogelmeier</surname><given-names>C</given-names></name><name><surname>Anzueto</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Global strategy for the diagnosis, management, and prevention of
chronic obstructive pulmonary disease: GOLD executive summary</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><issue>4</issue><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">22878278</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Symreng</surname><given-names>T</given-names></name><name><surname>Gomez</surname><given-names>MN</given-names></name><name><surname>Rossi</surname><given-names>N</given-names></name></person-group><article-title>Intrapleural bupivacaine v saline after thoracotomy--effects on pain
and lung function--a double-blind study</article-title><source>J Cardiothorac Anesth</source><year>1989</year><volume>3</volume><issue>2</issue><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">2519937</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sensoz</surname><given-names>Y</given-names></name><name><surname>Gunay</surname><given-names>R</given-names></name><name><surname>Tuygun</surname><given-names>AK</given-names></name><name><surname>Balci</surname><given-names>AY</given-names></name><name><surname>Sahin</surname><given-names>S</given-names></name><name><surname>Kayacioglu</surname><given-names>I</given-names></name><etal>et al</etal></person-group><article-title>Computed tomography evaluation of different chest tube sites for
residual pleural volumes after coronary artery bypass surgery</article-title><source>Ann Saudi Med</source><year>2011</year><volume>31</volume><issue>4</issue><fpage>383</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">21808115</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedenstierna</surname><given-names>G</given-names></name><name><surname>Edmark</surname><given-names>L</given-names></name></person-group><article-title>The effects of anesthesia and muscle paralysis on the respiratory
system</article-title><source>Intensive Care Med</source><year>2005</year><volume>31</volume><issue>10</issue><fpage>1327</fpage><lpage>1335</lpage><pub-id pub-id-type="pmid">16132894</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Alves</surname><given-names>FA</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name></person-group><article-title>Ministernotomy in myocardial revascularization preserves postoperative
pulmonary function</article-title><source>Arq Bras Cardiol</source><year>2010</year><volume>95</volume><issue>5</issue><fpage>587</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">20963310</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynne</surname><given-names>R</given-names></name><name><surname>Botti</surname><given-names>M</given-names></name></person-group><article-title>Postoperative pulmonary dysfunction in adults after cardiac surgery
with cardiopulmonary bypass: clinical significance and implications for
practice</article-title><source>Am J Crit Care</source><year>2004</year><volume>13</volume><issue>5</issue><fpage>384</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">15470854</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolla</surname><given-names>G</given-names></name><name><surname>Fogliati</surname><given-names>P</given-names></name><name><surname>Bucca</surname><given-names>C</given-names></name><name><surname>Brussino</surname><given-names>L</given-names></name><name><surname>Di Rosa</surname><given-names>E</given-names></name><name><surname>Di Summa</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Effect of pleurotomy on pulmonary function after coronary artery
bypass grafting with internal mammary artery</article-title><source>Respir Med</source><year>1994</year><volume>88</volume><issue>6</issue><fpage>417</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">7938791</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berdajs</surname><given-names>D</given-names></name><name><surname>Z&#x000fc;nd</surname><given-names>G</given-names></name><name><surname>Turina</surname><given-names>MI</given-names></name><name><surname>Genoni</surname><given-names>M</given-names></name></person-group><article-title>Blood supply of the sternum and its importance in internal thoracic
artery harvesting</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>81</volume><issue>6</issue><fpage>2155</fpage><lpage>2159</lpage><pub-id pub-id-type="pmid">16731146</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><etal>et al</etal></person-group><article-title>Influence of pleurotomy on pulmonary function after off-pump coronary
artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>84</volume><issue>3</issue><fpage>817</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">17720381</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakob</surname><given-names>H</given-names></name><name><surname>Kamler</surname><given-names>M</given-names></name><name><surname>Hagl</surname><given-names>S</given-names></name></person-group><article-title>Doubly angled pleural drain circumventing the transcostal route
relieves pain after cardiac surgery</article-title><source>Thorac Cardiovasc Surg</source><year>1997</year><volume>45</volume><issue>5</issue><fpage>263</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">9402674</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Ferraz</surname><given-names>RF</given-names></name><name><surname>Tavolaro</surname><given-names>K</given-names></name><name><surname>Cancio</surname><given-names>AA</given-names></name><etal>et al</etal></person-group><article-title>Pleurotomy with subxyphoid pleural drain affords similar effects to
pleural integrity in pulmonary function after off-pump coronary artery bypass
graft</article-title><source>J Cardiothorac Surg</source><year>2012</year><volume>7</volume><fpage>11</fpage><pub-id pub-id-type="pmid">22277597</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizak</surname><given-names>MK</given-names></name><name><surname>Nash</surname><given-names>E</given-names></name><name><surname>Zakliczynski</surname><given-names>M</given-names></name><name><surname>Sliwka</surname><given-names>J</given-names></name><name><surname>Knapik</surname><given-names>P</given-names></name><name><surname>Zembala</surname><given-names>M</given-names></name></person-group><article-title>Additional spirometry criteria predict postoperative complications
after coronary artery bypass grafting (CABG) independently of concomitant chronic
obstructive pulmonary disease: when is off-pump CABG more
beneficial?</article-title><source>Pol Arch Med Wewn</source><year>2009</year><volume>119</volume><issue>9</issue><fpage>550</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">19776699</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagl</surname><given-names>C</given-names></name><name><surname>Harringer</surname><given-names>W</given-names></name><name><surname>Gohrbandt</surname><given-names>B</given-names></name><name><surname>Haverich</surname><given-names>A</given-names></name></person-group><article-title>Site of pleural drain insertion and early postoperative pulmonary
function following coronary artery bypass grafting with internal mammary
artery</article-title><source>Chest</source><year>1999</year><volume>115</volume><issue>3</issue><fpage>757</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">10084489</pub-id></element-citation></ref></ref-list></back></article>